SCHEMBL3008249

SCHEMBL3008249

C1CCC(P(C2CCCCC2)C2CCCCC2)CC1.Cc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.49

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
TSHR P16473 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.48
ADORA3 P0DMS8 1/20 0.46
GAA P10253 1/20 0.44
KCNH2 Q12809 1/20 0.44
POLB P06746 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 3/20 0.43
EPHX2 P34913 1/20 0.43
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
ATM Q13315 1/20 0.42
HTT P42858 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL27563472 0.84 GAA (0.54) ALDH1A1TSHRCYP3A4CYP2D6GAA
Cyclopropane SCHEMBL2101355 0.84 GAA (0.54) ALDH1A1TSHRCYP3A4CYP2D6GAA
Cyclohexanol SCHEMBL1553521 0.83 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4CYP2D6ADORA3
Phosphine SCHEMBL28194487 0.82 GAA (0.52) ALDH1A1TSHRCYP3A4CYP2D6GAA
SCHEMBL6958251 0.81 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4CYP2D6ADORA3
Cyclohexylamine SCHEMBL11787101 0.81 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4CYP2D6ADORA3
Cyclopentanol SCHEMBL1554394 0.81 CYP2D6 (0.51) ALDH1A1TSHRCYP3A4CYP2D6ADORA3
SCHEMBL4824258 0.81 CYP2D6 (0.51) ALDH1A1TSHRCYP3A4CYP2D6ADORA3
SCHEMBL1500503 0.81 LMNA (0.49) ALDH1A1TSHRPOLBKDM4ELMNA
SCHEMBL631325 0.80 ALDH1A1 (0.61) ALDH1A1TSHRCYP3A4CYP2D6ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501985-B2 Use of phosphonium salts in coupling reactions and process for their manufacture DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2013-08-06 US claimed
US-20100197969-A1 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2010-08-05 US claimed
WO-2009013628-A2 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2009-01-29 WO claimed
EP-2019107-A1 Use of phosphonium salts in coupling reactions and process for their manufacture Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 2009-01-28 EP claimed
CN-1554680-A In mold addition polymerization composition of norbornene-type monomers and its crosslinking addition polymer ס�ѵ�ľ��ʽ���� 2004-12-15 CN claimed
CN-1333788-A In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes GOODRICH CO B F (US) 2002-01-30 CN claimed
CN-120152955-A Compositions comprising isomer mixtures of itaconimide norbornene and citraconimide norbornene 3M创新有限公司 2025-06-13 CN disclosed
CN-117295752-A Monomers, polymerizable compositions, and polymers derived therefrom 3M创新有限公司 2023-12-26 CN disclosed
CN-116490538-A Curable composition, syntactic foam, method of preparing syntactic foam, and article comprising syntactic foam 3M创新有限公司 2023-07-25 CN disclosed
US-8501985-B2 Use of phosphonium salts in coupling reactions and process for their manufacture DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2013-08-06 US disclosed
US-20100197969-A1 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2010-08-05 US disclosed
WO-2009013628-A2 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2009-01-29 WO disclosed
EP-2019107-A1 Use of phosphonium salts in coupling reactions and process for their manufacture Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 2009-01-28 EP disclosed
US-20070123667-A1 PROCESS FOR PRODUCING CYCLOOLEFIN ADDITION POLYMER JSR CORPORATION (JP) 2007-05-31 US disclosed
EP-1712572-A1 PROCESS FOR PRODUCING CYCLOOLEFIN ADDITION POLYMER JSR Corporation (JP) 2006-10-18 EP disclosed
US-20060217505-A1 Process for producing cycloolefin addition polymer JRS CORPORATION (JP) 2006-09-28 US disclosed
EP-1657259-A1 PROCESS FOR PRODUCING CYCLOOLEFIN ADDITION POLYMER JSR Corporation (JP) 2006-05-17 EP disclosed
CN-1555387-A Polymer composition for manufacturing optical waveguide, optical waveguide manufactured thereby, and method for manufacturing the waveguide 古德里奇公司 2004-12-15 CN disclosed
CN-1554680-A In mold addition polymerization composition of norbornene-type monomers and its crosslinking addition polymer ס�ѵ�ľ��ʽ���� 2004-12-15 CN disclosed
CN-1333788-A In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes GOODRICH CO B F (US) 2002-01-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197969-A1 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE PPIP5K2, PHOSPHO1, PNKP ALDH1A1 4586/4885TSHR 3068/4885CYP3A4 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.